In summary, through a proteome-wide large-scale two-sample MR analysis combined with colocalization analysis, we identified SLURP1, LY6D, WFDC1, NOV, and GSTM3 as potential plasma proteins associated with bladder cancer. The gene discussed is LY6D; the disease is urinary bladder carcinoma.